272 related articles for article (PubMed ID: 7506566)
1. Clonal chronic lymphocytic leukaemia-like B lymphocytes in the blood of patients with cutaneous T-cell disorders.
Daenen S; van Voorst Vader PC; Blom N; Pietens J; Hollema H; Smit JW
Br J Haematol; 1993 Oct; 85(2):307-12. PubMed ID: 7506566
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal T-cell dyscrasia of undetermined significance associated with recalcitrant erythroderma.
Gniadecki R; Lukowsky A
Arch Dermatol; 2005 Mar; 141(3):361-7. PubMed ID: 15781677
[TBL] [Abstract][Full Text] [Related]
3. Composite cutaneous T-cell lymphoma and small B-cell lymphocytic lymphoma: morphologic, immunologic, and molecular genetic documentation of concurrent lymph node involvement.
Liu YC; Tomashefski JF; Cleveland RP; Nassar SJ; Trey JE
Mod Pathol; 1994 Aug; 7(6):641-6. PubMed ID: 7991522
[TBL] [Abstract][Full Text] [Related]
4. CD5 expression in B-cell small lymphocytic malignancies. Correlations with clinical presentation and sites of disease.
Sundeen JT; Longo DL; Jaffe ES
Am J Surg Pathol; 1992 Feb; 16(2):130-7. PubMed ID: 1370753
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
Magro CM; Dyrsen ME
J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
[TBL] [Abstract][Full Text] [Related]
6. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
7. CD5 antigen expression in B cell chronic lymphocytic leukaemia.
Brohée D; Cauchie P; Nève P
Med Oncol; 1994; 11(3-4):137-8. PubMed ID: 7543349
[No Abstract] [Full Text] [Related]
8. Leukaemic cutaneous T-cell lymphoma-manifesting papuloerythroderma with CD3(-) CD4(+) phenotype.
Shimauchi T; Sugita K; Nakamura M; Tokura Y
Acta Derm Venereol; 2010; 90(1):68-72. PubMed ID: 20107729
[TBL] [Abstract][Full Text] [Related]
9. CD5+ leukemic monocytoid B-cell lymphoma and lymphocytic lymphomas.
Adami F; Semenzato G; Menestrina F; Chilosi M
Am J Clin Pathol; 1993 Aug; 100(2):187-8. PubMed ID: 7689294
[No Abstract] [Full Text] [Related]
10. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
[TBL] [Abstract][Full Text] [Related]
11. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic analysis of benign and malignant cutaneous lymphoid infiltrates.
Rest EB; Horn TD
Clin Dermatol; 1991; 9(2):261-72. PubMed ID: 1660786
[No Abstract] [Full Text] [Related]
13. Interleukin-7 receptor expression in cutaneous T-cell lymphomas.
Bagot M; Charue D; Boulland ML; Gaulard P; Revuz J; Schmitt C; Wechsler J
Br J Dermatol; 1996 Oct; 135(4):572-5. PubMed ID: 8915148
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients.
Beljaards RC; Kaudewitz P; Berti E; Gianotti R; Neumann C; Rosso R; Paulli M; Meijer CJ; Willemze R
Cancer; 1993 Mar; 71(6):2097-104. PubMed ID: 8382999
[TBL] [Abstract][Full Text] [Related]
15. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
16. Metachronous/concomitant B-cell neoplasms with discordant light-chain or heavy-chain isotype restrictions: evidence of distinct B-cell neoplasms rather than clonal evolutions.
Wei Q; Sebastian S; Papavassiliou P; Rehder C; Wang E
Hum Pathol; 2014 Oct; 45(10):2063-76. PubMed ID: 25179408
[TBL] [Abstract][Full Text] [Related]
17. Neoplastic erythema nodosum.
Matsuoka LY
J Am Acad Dermatol; 1995 Feb; 32(2 Pt 2):361-3. PubMed ID: 7530263
[TBL] [Abstract][Full Text] [Related]
18. Lymphomatoid papulosis and Ki-1 (CD30)-positive cutaneous large cell lymphomas.
Kaudewitz P; Burg G
Semin Diagn Pathol; 1991 May; 8(2):117-24. PubMed ID: 1651550
[No Abstract] [Full Text] [Related]
19. Leukemia-associated changes identified by quantitative flow cytometry. III. B-cell gating in CD37/kappa/lambda clonality test.
Peters RE; Janossy G; Ivory K; al-Ismail S; Mercolino T
Leukemia; 1994 Nov; 8(11):1864-70. PubMed ID: 7967732
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
